If you follow the health sector, GE HealthCare (GEHC +1.54%) stock may be on your radar. GE HealthCare Technologies is a medical technology company that was formed in January 2023 after completing a spinoff from GE (GE +2.85%).
GE HealthCare has four main business segments: imaging, ultrasound, patient care solutions, and pharmaceutical diagnostics. The company is a global leader in medical imaging, which accounts for just over half its revenue, and has also invested heavily in AI for healthcare technologies.
GE HealthCare could benefit from several trends, including an aging population, growing demand for advanced diagnostics and precision medicine, and improving healthcare access and infrastructure in emerging markets. However, the stock isn't without risks. Let's explore how to invest in GE HealthCare stock and if shares of its stocks fit into your portfolio.

NASDAQ: GEHC
Key Data Points
How to buy GE HealthCare stock
Practically anyone can buy stock in GE HealthCare and other publicly traded companies by following these steps:
- Open your brokerage account: Log in to your brokerage account where you handle your investments.
- Search for the stock: Enter the ticker or company name into the search bar to bring up the stock's trading page.
- Decide how many shares to buy: Consider your investment goals and how much of your portfolio you want to allocate to this stock.
- Select order type: Choose between a market order to buy at the current price or a limit order to specify the maximum price you're willing to pay.
- Submit your order: Confirm the details and submit your buy order.
- Review your purchase: Check your portfolio to ensure your order was filled as expected and adjust your investment strategy accordingly.
Stock
Is GE HealthCare profitable?
GE HealthCare is profitable. In 2023, its first year as a publicly traded company, GE HealthCare reported net income of $1.6 billion, down slightly from the previous year's $1.9 billion. The company's net revenue grew by 7% during the fiscal year.
GE HealthCare also invested $1 billion in R&D and paid down $1 billion in debt during its first year as a standalone company.
By the end of June 2025, GE HealthCare reported $1.08 billion in net income and a 3% boost in revenue year-over-year. According to GE HealthCare's Q2 financial report, GE HealthCare President and CEO Peter Arduini said, “We were pleased with solid orders and revenue performance in the second quarter across all segments, reflecting healthy customer investment in capital equipment.
Does GE HealthCare pay a dividend?
Since spinning off into its own company in early 2023, GE HealthCare has paid a modest quarterly dividend of $0.03 per share. Based on its share price in late 2025, its annual dividend yield was 0.18%.
GE HealthCare has generated healthy revenues, profits, and free cash flow since completing its spinoff, all of which bode well for its ability to maintain and grow its dividend. However, the company also invests heavily in research and development, and reinvesting its profits into new technologies is likely to take priority over dividend payments.
Exchange-Traded Fund (ETF)
Will GE HealthCare stock split?
GE HealthCare hasn't split its stock in its brief time as a publicly traded company and has not announced plans for an upcoming stock split. Companies often split their stock to make it more attainable to investors after share prices have skyrocketed.
As of October 2025, GE HealthCare's shares traded for about $76, which doesn't seem likely to scare off investors -- so a stock split is fairly unlikely in the near future.
Related investing topics
The bottom line on GE HealthCare stock
GE HealthCare stock has significant growth potential, particularly in artificial intelligence (AI) technologies. It also stands to benefit from several trends, like a focus on advanced diagnostics and preventative care, along with a graying population.
However, the company's success depends on heavy investment in R&D, which doesn't pay off overnight. Investors seeking quick profits or high dividend yields should put their money elsewhere.



















